Journal of Oral Science Research ›› 2016, Vol. 32 ›› Issue (10): 1042-1046.DOI: 10.13701/j.cnki.kqyxyj.2016.10.010

Previous Articles     Next Articles

Antibacterial Effects of Lactobacillus Salivarius W22a on the Periodontal Pathogens.

XUE Long1,4, WANG Li-he1,4, NIE Hong-bing2,3*, ZHOU Hai-jing2,3, GUO Man-li2,3, KANG Yong-jie1,4, YANG Lan1*.   

  1. 1. Department of Oral and Maxillofacial Surgery, The Second Hospital of Lanzhou University, Lanzhou 730000, China;
    2. Key Laboratory of Oral Diseases of Gansu Provincial, Northwest University for Nationalities, Lanzhou 730000, China;
    3.Key Lab of Stomatology of State Ethnic Affairs Commission, Northwest University for Nationalities, Lanzhou 730030, China;
    4.School of Stomatology, Lanzhou University, Lanzhou 730000, China
  • Received:2016-03-28 Online:2016-10-26 Published:2016-10-26

Abstract: Objective: To evaluate whether the oral administration of Lactobacillus salivarius w22a could alleviate the peri-implantitis pathogens in subgingival plaque, such as Porphyromonas gingivalis (Pg), Pevotella intermedia (Pi), and Fusobacteriurn nuclearum (Fn) in vitro.Methods: The antagonistic growth effects of Lactobacillus salivarius as well as their probiotic on periodontal pathogens, including Pg, Pi and Fn, were tested using drug resistance experiment, agglutination experiments, and antibacterial experiments.Results: The results revealed that Lactobacillus salivarius w22a could produce antibiotics such as organic acid, hydrogen peroxide and EPS. Strain w22a could resist lysozyme and antibiotics at certain concentration. In addition, auto-agglutination and agglutination with other pathogens could be observed. The fermentation of w22a inhibited the growth of pathogens to varied degrees.Conclusion: Lactobacillus salivarius w22a was a potential probiotic strain to inhibit the growth of Pg, Pi and Fn in vitro.

Key words: Lactobacillus salivarius, Probiotic, Peri-implantitis

CLC Number: